Trending

Featured

March 19, 2024

Rapport Therapeutics Appoints John Maraganore to Board of Directors

BOSTON & SAN DIEGO--(BUSINESS WIRE)--Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging... Read more »

March 7, 2024

Johnson & Johnson Completes Ambrx Acquisition

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced today it has successfully completed... Read more »

March 5, 2024

Interview with Steve Holtzclaw, CEO at U.S. Orthopaedic Partners

Steve Holtzclaw, MD, MBA, is the CEO of U.S. Orthopaedic Partners, a position he assumed on January 1, 2024... Read more »

citybiz
Gain exposure through our multi-channel news platform.
For AgenciesFor Enterprise
April 9, 2024

2024’s Best & Worst States for Children’s Health Care – WalletHub Study

April 3, 2024

Maverix Medical Acquires Cirrus Bio

April 1, 2024

Healthiest Cities in America (2024 Rankings) – WalletHub Study

March 26, 2024

Gilead Sciences Acquires CymaBay, For Approximately $4.3 Billion

March 21, 2024

Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues

March 18, 2024

2024’s Best & Worst States for Doctors – WalletHub Study

March 14, 2024

Pfizer: It’s Darkest Before The Dawn, Upgrading To ‘Strong Buy’

March 11, 2024

2024’s Most Overweight and Obese Cities in the U.S. – WalletHub Study

March 7, 2024

Rakuten Medical Closes $119M Series E

March 7, 2024

Vivani Medical Appoints Daniel Bradbury To Its Board

March 6, 2024

Woodbridge International Closes Sale of Rayotek Scientific to McDanel Advanced Material Technologies

February 28, 2024

Rapport Therapeutics Appoints Kathy Wilkinson as Chief People Officer

February 26, 2024

Bristol Myers Squibb Completes Acquisition of RayzeBio

February 26, 2024

iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka

February 15, 2024

Latigo Biotherapeutics Raises $135M in Series A

February 14, 2024

Pfizer Stock: It’s Time To Buy The Dip